Walmart is in early talks to acquire health insurer Humana, the Wall Street Journal reported, a transaction that would pitch the retailer headlong into a rapidly changing industry whose surging costs and regulatory pressures have led to a series of megadeals.
The details of the discussions aren’t clear, and a deal may fall through, the Journal said, citing unidentified people familiar with the matter. Humana, valued at about $37 billion, would be Walmart’s largest deal on record. Walmart declined to comment to Bloomberg News, while Humana didn’t immediately respond.
For Walmart, which operates thousands of pharmacies in its stores, the logic of buying an insurer could be similar to drugstore chain CVS’s plan — gaining more leverage in negotiations with drug companies by taking up a bigger share of purchasing power for pharmaceuticals.
Walmart and Humana already partner on prescription drug plans for individuals in the US Medicare program. The plans offer some prescriptions for as little as $1, as long as customers pick up their drugs at a Walmart or Sam’s Club. Walmart could use the takeover to steer more of Humana’s customers to its stores through its drug coverage arrangements.
Full Content: Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Antitrust Trial Explores Potential Impact of Tapestry-Capri Merger
Sep 12, 2024 by
CPI
Australia Targets Big Tech with New Fines for Misinformation
Sep 12, 2024 by
CPI
Mastercard to Acquire Cybersecurity Firm Recorded Future for $2.65 Billion
Sep 12, 2024 by
CPI
Ireland Prime Minister: Apple’s €13 Billion Payment Could Fund Housing and Capital Projects
Sep 12, 2024 by
CPI
Regulators Probe Swisscom’s $8.8 Billion Vodafone Italia Deal
Sep 12, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Canada & Mexico
Sep 3, 2024 by
CPI
Competitive Convergence: Mexico’s 30-Year Quest for Antitrust Parity with its Northern Neighbor
Sep 3, 2024 by
Francisco Javier Núñez Melgoza
Competition and Digital Markets in North America: A Comparative Study of Antitrust Investigations in Mexico and the United States
Sep 3, 2024 by
Julio Garcia
Recent Antitrust Development in Mexico: COFECE’s Preliminary Report on Amazon and Mercado Libre
Sep 3, 2024 by
Alejandra Palacios Prieto
The Cost of Making COFECE Disappear
Sep 3, 2024 by
Mateo Fernández